CPAP Effect on Vascular Function in Obstructive Sleep Apnea (VNI-SOH2)
Long Term Effects of Positive Airway Pressure Therapies on Vascular Function in Obstructive Sleep Apnea
Obstructive sleep apnea syndrome is responsible of endothelial dysfunction, which is a independent cardio-vascular risk factor.
Assessment of pulse wave velocity (PWV) and peripheral arterial tone (PAT) are study measurements of arterial stiffness, and are strong predictors of late cardiovascular events.
This study will compare long term evolution in arterial stiffness (PWV) and endothelial dysfunction (PAT) for patients treated by Positive Airway Pressure Therapies.
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
Obstructive sleep apnea (OSA) syndrome is responsible of vascular damage. Intermittent hypoxia causes oxidative stress and low-grade inflammation. By the way of increased sympathetic outflow, it's resulting endothelial dysfunction, atherosclerosis and an increase of arterial stiffness.
Finally these mechanisms are responsible of cardiovascular comorbidities: hypertension, cardiac arrhythmias or Left ventricular dysfunction. This patients presented coronary diseases or Strokes.
OSA characterized by intermittent hypoxia, is associated with atherosclerosis and vascular inflammation. Polymorphonuclear leukocytes (PMNs) are implicated in vascular inflammation by producing oxidizing radicals and proteolytic enzymes during PMN-endothelium interactions.
Reactive oxygen species (ROS) production is increased in activated cells and after attachment, PMNs release additional ROS inducing endothelial cell injury.
Continuous positive airway pressure (CPAP) is the current "gold standard" treatment for OSA, Use of CPAP restored the respiratory flow, prevents nocturnal respiratory events and daytime symptoms.
Arterial stiffness and endothelial dysfunction are linked to obstructive sleep apnea severity with a dose-effect relationship. And meta-analyse showed significant improvements in all indices of arterial stiffness after CPAP treatment in patients with OSA.
Assessment of pulse wave velocity and peripheral arterial tone are study measurements of arterial stiffness. And are strong predictors of late cardiovascular events
The investigators will compare long term evolution in arterial stiffness (PWV) and endothelial dysfunction (Peripheral arterial tone) for patients with OSA treated by Positive Airway Pressure Therapies.
Tipo de estudio
Inscripción (Actual)
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
-
Grenoble, Francia, 38000
- University Hospital Grenoble
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Método de muestreo
Población de estudio
Descripción
Inclusion Criteria:
- Any patient with a initial visit there is 4-7 years for the VNI-SOH protocol (Réf CPP Sud-Est V: 38/2006/2)
- Male or female patient, aged 20-75 years at the initial visit there is 4 to 7 years;
- Patients with a BMI> 30kg / m2 at diagnostic;
- Patient affiliated to a social security;
- Having given its written consent to participate in the study.
Exclusion Criteria:
- Person private of liberty by judicial or administrative decision, person under legal protection measure (pregnant or nursing, patient under guardianship) Article L1121-8
- Exclusion period for further studies
- Patient died or lost sight since the initial visit there 4-7 years
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
Cohortes e Intervenciones
Grupo / Cohorte |
Intervención / Tratamiento |
|---|---|
|
PAP therapies
Patients with sleep apnea syndrome treated by CPAP after respiratory and vascular assessment and followed 5-7 years, as part of a clinical research.
|
Patients with sleep apnea syndrome treated by PAP Therapies (CPAP) after diagnosis and followed 5-7 years.
Otros nombres:
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Periodo de tiempo |
|---|---|
|
Long term evolution in arterial stiffness by pulse wave velocity
Periodo de tiempo: 4 to 7 years from baseline assessment
|
4 to 7 years from baseline assessment
|
Medidas de resultado secundarias
Medida de resultado |
Periodo de tiempo |
|---|---|
|
Endothelial dysfunction by peripheral arterial tone
Periodo de tiempo: 4 to 7 years from baseline assessment
|
4 to 7 years from baseline assessment
|
|
Parameters of systemic inflammation : CRP us, TNF-α, IL-6 , Leptin in blood sampling
Periodo de tiempo: 4 to 7 years from baseline assessment
|
4 to 7 years from baseline assessment
|
|
Parameters of insulin resistance : glycated hemoglobin (HbA1C), blood sugar, insulin
Periodo de tiempo: 4 to 7 years from baseline assessment
|
4 to 7 years from baseline assessment
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Jean-Louis Pépin, MDPhD, University Hospital, Grenoble
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Estimar)
Actualizaciones de registros de estudio
Última actualización publicada (Estimar)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- 38RC14.422
- 2014-A01922-45 (Otro identificador: ID RCB)
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .
Ensayos clínicos sobre PAP Therapies (CPAP)
-
Oslo University HospitalResMed; Medtronic; Norwegian Health AssociationTerminadoApnea del sueño | Respiración desordenada del sueño | Fibrilación auricular paroxísticaNoruega
-
Seattle Children's HospitalNationwide Children's HospitalDesconocidoNacimiento prematuroEstados Unidos
-
Stanford UniversityTerminadoApnea del Sueño ObstructivaEstados Unidos
-
Hadassah Medical OrganizationUniversity of RochesterDesconocidoEl embarazo | Apnea del sueño
-
VA Office of Research and DevelopmentReclutamientoApnea obstructiva del sueño | Trastorno por uso de sustancias | Trastorno de estrés postraumático | Programa de Tratamiento ResidencialEstados Unidos
-
Patri-cia Angelica de Miranda Silva NogueiraTerminadoInsuficiencia cardiaca
-
McGill University Health Centre/Research Institute...Canadian Institutes of Health Research (CIHR); American Thoracic SocietyTerminadoEnfermedad de Parkinson | Apnea obstructiva del sueñoCanadá
-
University of California, San DiegoNational Heart, Lung, and Blood Institute (NHLBI)ReclutamientoDolor | Dolor crónico | Desorden del sueño | Dormir | Apnea obstructiva del sueño | Apnea del sueño | Uso de opioides | Desorden del sueño; Relacionado con la respiraciónEstados Unidos
-
University of MichiganTerminadoTrastorno depresivo mayor | Respiración trastornada del sueñoEstados Unidos
-
University of MichiganNational Heart, Lung, and Blood Institute (NHLBI); Michigan Technological UniversityTerminadoSíndromes de apnea del sueño | Apnea del Sueño Obstructiva | Trastornos de somnolencia excesiva | Trastorno por Déficit de Atención con Hiperactividad | Trastornos del comportamiento infantilEstados Unidos